Gene Symbol | Gene ID | Gene Info |
---|---|---|
Olig2
|
ENSMUSG00000039830.8 | oligodendrocyte transcription factor 2 |
Olig3
|
ENSMUSG00000045591.5 | oligodendrocyte transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_91225253_91225471 | Olig2 | 95 | 0.945550 | 0.76 | 1.5e-11 | Click! |
chr16_91224822_91224991 | Olig2 | 551 | 0.630822 | 0.69 | 6.5e-09 | Click! |
chr16_91225529_91225867 | Olig2 | 241 | 0.875205 | 0.69 | 7.7e-09 | Click! |
chr16_91232174_91232468 | Olig2 | 6864 | 0.124912 | 0.68 | 1.2e-08 | Click! |
chr16_91227074_91227225 | Olig2 | 1692 | 0.247978 | 0.63 | 3.2e-07 | Click! |
chr10_19373819_19374132 | Olig3 | 17442 | 0.219904 | 0.75 | 3.7e-11 | Click! |
chr10_19329521_19329721 | Olig3 | 26912 | 0.174439 | 0.65 | 9.1e-08 | Click! |
chr10_19396813_19397100 | Olig3 | 40423 | 0.159736 | 0.63 | 2.3e-07 | Click! |
chr10_19339085_19339236 | Olig3 | 17373 | 0.204435 | 0.62 | 5.8e-07 | Click! |
chr10_19396571_19396796 | Olig3 | 40150 | 0.160481 | 0.61 | 8.6e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_13678237_13678562 | 30.39 |
AC103362.1 |
novel transcript |
76999 |
0.12 |
chr2_20476541_20476842 | 26.43 |
Etl4 |
enhancer trap locus 4 |
33356 |
0.19 |
chr4_111866796_111866947 | 26.02 |
Slc5a9 |
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
13756 |
0.18 |
chr5_98139023_98139203 | 24.36 |
Gm8048 |
predicted gene 8048 |
14068 |
0.16 |
chr6_146282139_146282319 | 24.15 |
Gm44086 |
predicted gene, 44086 |
11249 |
0.21 |
chr4_87928972_87929158 | 23.72 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
54523 |
0.14 |
chr4_64598592_64598752 | 23.29 |
Gm23950 |
predicted gene, 23950 |
153942 |
0.04 |
chr1_134024711_134024876 | 23.24 |
Gm18970 |
predicted gene, 18970 |
8585 |
0.15 |
chr11_44977922_44978106 | 22.16 |
Ebf1 |
early B cell factor 1 |
65876 |
0.13 |
chr6_85218363_85218514 | 21.85 |
Emx1 |
empty spiracles homeobox 1 |
24919 |
0.12 |
chr1_24226131_24226533 | 20.95 |
Col9a1 |
collagen, type IX, alpha 1 |
3185 |
0.33 |
chr18_29516319_29516485 | 20.67 |
4930578E11Rik |
RIKEN cDNA 4930578E11 gene |
19833 |
0.26 |
chr3_51096175_51096378 | 20.54 |
Gm38246 |
predicted gene, 38246 |
7384 |
0.2 |
chr17_87745290_87745662 | 20.35 |
Msh2 |
mutS homolog 2 |
48935 |
0.12 |
chr13_77295666_77295844 | 20.35 |
2210408I21Rik |
RIKEN cDNA 2210408I21 gene |
102721 |
0.07 |
chr14_62455363_62455547 | 20.31 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
662 |
0.68 |
chr3_107114477_107114841 | 19.63 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11977 |
0.14 |
chr10_110192564_110192756 | 19.63 |
Gm47340 |
predicted gene, 47340 |
52491 |
0.15 |
chr8_12126666_12127044 | 19.53 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151964 |
0.03 |
chr3_124157954_124158110 | 19.42 |
Gm43731 |
predicted gene 43731 |
88205 |
0.08 |
chr12_66889371_66889522 | 19.35 |
Gm18940 |
predicted gene, 18940 |
43856 |
0.16 |
chr3_47863616_47863904 | 18.56 |
Gm7977 |
predicted gene 7977 |
163000 |
0.04 |
chr3_50044774_50044968 | 18.38 |
Gm37826 |
predicted gene, 37826 |
15202 |
0.23 |
chr16_63806861_63807216 | 18.25 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chrX_61823685_61823865 | 18.23 |
Gm6743 |
predicted pseudogene 6743 |
6735 |
0.25 |
chr16_84875745_84875916 | 18.20 |
Gabpa |
GA repeat binding protein, alpha |
15785 |
0.14 |
chr5_78993374_78993615 | 18.12 |
Gm25756 |
predicted gene, 25756 |
213635 |
0.02 |
chr5_8224017_8224168 | 17.95 |
Gm23993 |
predicted gene, 23993 |
18631 |
0.17 |
chr12_6638821_6639107 | 17.59 |
Gm48619 |
predicted gene, 48619 |
60789 |
0.16 |
chr5_70024646_70024993 | 17.56 |
Gm43139 |
predicted gene 43139 |
93011 |
0.08 |
chr1_55489399_55489736 | 17.56 |
Gm6644 |
predicted gene 6644 |
44543 |
0.12 |
chr5_47794978_47795129 | 17.54 |
Gm3010 |
predicted gene 3010 |
95208 |
0.08 |
chr3_81025689_81025905 | 17.54 |
Gm42476 |
predicted gene 42476 |
7157 |
0.16 |
chr15_25019653_25019899 | 17.49 |
Gm2824 |
predicted gene 2824 |
1382 |
0.54 |
chr12_47164923_47165105 | 17.46 |
Gm36971 |
predicted gene, 36971 |
28 |
0.99 |
chr9_118455480_118455793 | 17.45 |
Gm22479 |
predicted gene, 22479 |
11428 |
0.13 |
chr14_93182695_93182874 | 17.11 |
Gm9247 |
predicted gene 9247 |
12912 |
0.21 |
chr4_53896505_53896735 | 17.07 |
Gm23745 |
predicted gene, 23745 |
9076 |
0.17 |
chr16_27925838_27926060 | 16.90 |
Gm49765 |
predicted gene, 49765 |
44396 |
0.17 |
chr16_77536418_77536599 | 16.78 |
Gm36963 |
predicted gene, 36963 |
3374 |
0.16 |
chr5_110611527_110611728 | 16.47 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
8105 |
0.13 |
chr13_47413566_47413717 | 16.39 |
Gm35733 |
predicted gene, 35733 |
52255 |
0.15 |
chr3_17847688_17847864 | 16.22 |
Gm23441 |
predicted gene, 23441 |
44029 |
0.13 |
chr16_67611348_67611518 | 16.20 |
Cadm2 |
cell adhesion molecule 2 |
9060 |
0.25 |
chr3_42892344_42892576 | 16.17 |
Gm38044 |
predicted gene, 38044 |
306861 |
0.01 |
chr9_119510823_119511314 | 15.94 |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
51610 |
0.1 |
chr19_48429427_48429578 | 15.92 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
458 |
0.9 |
chr12_32717261_32717460 | 15.86 |
Gm18726 |
predicted gene, 18726 |
7199 |
0.24 |
chr19_26770137_26770516 | 15.83 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr6_14819892_14820231 | 15.82 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
64787 |
0.14 |
chr5_46202535_46202686 | 15.76 |
Gm7931 |
predicted pseudogene 7931 |
211734 |
0.02 |
chr5_70501492_70501643 | 15.76 |
Gm26072 |
predicted gene, 26072 |
49380 |
0.15 |
chr9_73258155_73258537 | 15.66 |
Gm27211 |
predicted gene 27211 |
65863 |
0.09 |
chr16_26827135_26827286 | 15.65 |
Gm20319 |
predicted gene, 20319 |
71708 |
0.12 |
chr7_73917720_73918558 | 15.59 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr4_72572146_72572321 | 15.55 |
Gm11235 |
predicted gene 11235 |
29567 |
0.25 |
chr12_51241510_51241681 | 15.52 |
Rps11-ps4 |
ribosomal protein S11, pseudogene 4 |
55892 |
0.14 |
chr13_83884765_83885152 | 15.52 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
6250 |
0.23 |
chr6_91359766_91359963 | 15.39 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
5207 |
0.18 |
chr3_49009210_49009530 | 15.37 |
Gm31415 |
predicted gene, 31415 |
53008 |
0.14 |
chr8_53892879_53893080 | 15.18 |
Gm19921 |
predicted gene, 19921 |
18760 |
0.29 |
chr6_44408861_44409116 | 15.11 |
Gm44211 |
predicted gene, 44211 |
258447 |
0.02 |
chr13_84751597_84751791 | 15.10 |
Gm26913 |
predicted gene, 26913 |
60753 |
0.15 |
chr2_22166043_22166194 | 15.07 |
Myo3a |
myosin IIIA |
61385 |
0.14 |
chr6_61296445_61296613 | 15.01 |
Ccser1 |
coiled-coil serine rich 1 |
14326 |
0.26 |
chr14_8867695_8867984 | 15.01 |
Gm48364 |
predicted gene, 48364 |
7789 |
0.26 |
chr12_5087845_5088059 | 15.00 |
Gm9110 |
predicted gene 9110 |
20504 |
0.21 |
chr12_56234672_56234844 | 14.95 |
Gm25917 |
predicted gene, 25917 |
17686 |
0.15 |
chr9_41593345_41593581 | 14.85 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4969 |
0.12 |
chr1_57302006_57302319 | 14.73 |
Gm5254 |
predicted gene 5254 |
9761 |
0.21 |
chr1_126153911_126154172 | 14.68 |
Gm37936 |
predicted gene, 37936 |
82580 |
0.1 |
chr9_41375999_41376652 | 14.64 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr2_43097974_43098138 | 14.61 |
Gm24350 |
predicted gene, 24350 |
289021 |
0.01 |
chr17_69769280_69769433 | 14.59 |
Gm49895 |
predicted gene, 49895 |
6656 |
0.3 |
chr2_125031910_125032078 | 14.56 |
Slc24a5 |
solute carrier family 24, member 5 |
36130 |
0.16 |
chr12_50084531_50084873 | 14.48 |
Gm40418 |
predicted gene, 40418 |
35607 |
0.24 |
chr4_79310443_79310594 | 14.45 |
Gm11263 |
predicted gene 11263 |
17190 |
0.27 |
chr15_69923314_69923491 | 14.39 |
Gm19782 |
predicted gene, 19782 |
88221 |
0.1 |
chr19_15658752_15658903 | 14.34 |
Gm24319 |
predicted gene, 24319 |
21177 |
0.27 |
chr13_83736071_83736420 | 14.32 |
Gm33366 |
predicted gene, 33366 |
2290 |
0.18 |
chr10_97078273_97078452 | 14.32 |
Gm48555 |
predicted gene, 48555 |
28222 |
0.19 |
chr10_19277111_19277443 | 14.32 |
Gm33056 |
predicted gene, 33056 |
13712 |
0.19 |
chr9_27091470_27091656 | 14.28 |
Gm48796 |
predicted gene, 48796 |
6988 |
0.16 |
chr14_73425532_73425687 | 14.19 |
Itm2b |
integral membrane protein 2B |
40320 |
0.14 |
chr17_49867296_49868004 | 14.16 |
Kif6 |
kinesin family member 6 |
19978 |
0.17 |
chr14_79905756_79905979 | 14.15 |
Gm49542 |
predicted gene, 49542 |
7400 |
0.17 |
chr6_55792592_55792989 | 14.14 |
Itprid1 |
ITPR interacting domain containing 1 |
44105 |
0.18 |
chr18_45946212_45946693 | 14.12 |
Gm26262 |
predicted gene, 26262 |
5445 |
0.28 |
chr14_9811613_9812129 | 14.12 |
Hmgb3-ps |
Hmgb3 retrotransposed pseudogene |
51231 |
0.15 |
chr13_83727100_83727308 | 14.10 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
902 |
0.45 |
chr16_72772461_72772624 | 14.10 |
Robo1 |
roundabout guidance receptor 1 |
109338 |
0.08 |
chr6_104313110_104313279 | 14.07 |
Gm18100 |
predicted gene, 18100 |
13068 |
0.31 |
chr8_12126295_12126640 | 14.05 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr8_32958865_32959235 | 13.97 |
Gm3985 |
predicted gene 3985 |
9024 |
0.28 |
chr14_113887365_113887524 | 13.97 |
Gm5209 |
predicted gene 5209 |
14583 |
0.31 |
chr18_40459021_40459343 | 13.96 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
chr19_59542425_59542623 | 13.96 |
Gm18161 |
predicted gene, 18161 |
2073 |
0.35 |
chr1_127537694_127537960 | 13.93 |
Tmem163 |
transmembrane protein 163 |
397 |
0.9 |
chr14_49311354_49311519 | 13.93 |
Slc35f4 |
solute carrier family 35, member F4 |
2773 |
0.26 |
chr5_68149972_68150304 | 13.90 |
Gm43025 |
predicted gene 43025 |
65764 |
0.11 |
chr10_7268395_7268800 | 13.90 |
Cnksr3 |
Cnksr family member 3 |
56360 |
0.14 |
chr1_32463374_32463525 | 13.87 |
Gm37999 |
predicted gene, 37999 |
10308 |
0.17 |
chr2_96763491_96763847 | 13.83 |
Gm17075 |
predicted gene 17075 |
235955 |
0.02 |
chr19_19306553_19306736 | 13.81 |
Gm41815 |
predicted gene, 41815 |
30173 |
0.17 |
chr8_125080980_125081334 | 13.79 |
Disc1 |
disrupted in schizophrenia 1 |
6830 |
0.19 |
chr2_126735451_126735631 | 13.79 |
Gm10774 |
predicted pseudogene 10774 |
25984 |
0.12 |
chr8_54991954_54992136 | 13.79 |
Gm45265 |
predicted gene 45265 |
13240 |
0.14 |
chr6_143359440_143359700 | 13.76 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
73520 |
0.1 |
chr2_62361658_62361809 | 13.76 |
Dpp4 |
dipeptidylpeptidase 4 |
4026 |
0.21 |
chr3_126810807_126810958 | 13.75 |
Camk2d |
calcium/calmodulin-dependent protein kinase II, delta |
3720 |
0.24 |
chr11_18413972_18414175 | 13.75 |
Gm37869 |
predicted gene, 37869 |
22169 |
0.21 |
chr16_42616018_42616202 | 13.74 |
Gm49739 |
predicted gene, 49739 |
47816 |
0.19 |
chr4_96697628_96698496 | 13.70 |
Cyp2j5 |
cytochrome P450, family 2, subfamily j, polypeptide 5 |
33908 |
0.19 |
chr3_11261156_11261347 | 13.68 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr10_78727991_78728196 | 13.66 |
Casp14 |
caspase 14 |
9799 |
0.11 |
chrX_14274069_14274220 | 13.64 |
Gm14867 |
predicted gene 14867 |
15595 |
0.23 |
chr15_103518626_103518966 | 13.64 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3876 |
0.17 |
chr2_48099294_48099480 | 13.63 |
Gm13471 |
predicted gene 13471 |
40759 |
0.22 |
chr12_25871193_25871842 | 13.63 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr2_51753056_51753280 | 13.58 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr3_10892120_10892293 | 13.57 |
Gm22795 |
predicted gene, 22795 |
83380 |
0.09 |
chr7_117595506_117595657 | 13.57 |
Xylt1 |
xylosyltransferase 1 |
120089 |
0.06 |
chr11_71675778_71675956 | 13.56 |
Gm12324 |
predicted gene 12324 |
17390 |
0.15 |
chr2_178141291_178141933 | 13.56 |
Phactr3 |
phosphatase and actin regulator 3 |
321 |
0.92 |
chr9_41665287_41665482 | 13.53 |
Gm48784 |
predicted gene, 48784 |
9670 |
0.14 |
chr14_84750390_84750558 | 13.51 |
Gm7004 |
predicted gene 7004 |
8609 |
0.33 |
chr7_71488400_71488557 | 13.51 |
Gm29328 |
predicted gene 29328 |
118145 |
0.05 |
chr12_26631442_26631804 | 13.46 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
29314 |
0.19 |
chr2_137694036_137694202 | 13.38 |
Gm14064 |
predicted gene 14064 |
30684 |
0.26 |
chr1_158490251_158490425 | 13.34 |
Mir488 |
microRNA 488 |
15287 |
0.17 |
chr17_43820987_43821190 | 13.33 |
Rcan2 |
regulator of calcineurin 2 |
17085 |
0.24 |
chr10_115776717_115776869 | 13.32 |
Tspan8 |
tetraspanin 8 |
40039 |
0.19 |
chr12_67009324_67009475 | 13.28 |
Gm47989 |
predicted gene, 47989 |
66988 |
0.13 |
chr10_18020913_18021146 | 13.26 |
Abracl |
ABRA C-terminal like |
1849 |
0.33 |
chr10_96546092_96546269 | 13.24 |
Gm48505 |
predicted gene, 48505 |
22198 |
0.18 |
chr13_114131052_114131240 | 13.20 |
Gm47479 |
predicted gene, 47479 |
10730 |
0.21 |
chr8_4206127_4207837 | 13.19 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr1_176994684_176995057 | 13.13 |
Sdccag8 |
serologically defined colon cancer antigen 8 |
3139 |
0.19 |
chr2_179390878_179391071 | 13.12 |
4930591A17Rik |
RIKEN cDNA 4930591A17 gene |
23962 |
0.19 |
chr5_13667586_13667737 | 13.12 |
Gm43718 |
predicted gene 43718 |
49846 |
0.12 |
chr1_114862898_114863053 | 13.12 |
Gm4854 |
predicted gene 4854 |
356788 |
0.01 |
chr3_115562856_115563010 | 13.12 |
Gm43669 |
predicted gene 43669 |
44357 |
0.16 |
chr7_48779139_48779290 | 13.11 |
Zdhhc13 |
zinc finger, DHHC domain containing 13 |
9789 |
0.16 |
chr10_92162409_92163019 | 13.09 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr16_25255884_25256063 | 13.04 |
Tprg |
transformation related protein 63 regulated |
30844 |
0.25 |
chr14_8511508_8511673 | 13.03 |
Gm8416 |
predicted gene 8416 |
102673 |
0.06 |
chr1_79212604_79212783 | 13.02 |
Gm29536 |
predicted gene 29536 |
11818 |
0.3 |
chr1_25086090_25086253 | 13.02 |
Gm29414 |
predicted gene 29414 |
58939 |
0.11 |
chr2_29320552_29320703 | 13.02 |
Med27 |
mediator complex subunit 27 |
26192 |
0.17 |
chr14_98810236_98810397 | 12.97 |
Gm27034 |
predicted gene, 27034 |
95503 |
0.07 |
chr1_94136816_94136967 | 12.95 |
Gm7891 |
predicted gene 7891 |
67526 |
0.1 |
chr18_4092130_4092281 | 12.93 |
Gm6248 |
predicted gene 6248 |
39669 |
0.16 |
chr12_26936808_26937007 | 12.93 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
102034 |
0.08 |
chr7_51784299_51784690 | 12.92 |
Gm29296 |
predicted gene 29296 |
11768 |
0.17 |
chr15_85991573_85992022 | 12.92 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
13067 |
0.2 |
chr16_57389949_57390100 | 12.91 |
Filip1l |
filamin A interacting protein 1-like |
36747 |
0.14 |
chr15_19667510_19667673 | 12.88 |
Gm49166 |
predicted gene, 49166 |
10641 |
0.27 |
chr13_112508598_112508749 | 12.87 |
Il31ra |
interleukin 31 receptor A |
23671 |
0.15 |
chr5_89814676_89814843 | 12.85 |
Gm25758 |
predicted gene, 25758 |
14112 |
0.27 |
chr1_61111831_61111982 | 12.80 |
Gm11590 |
predicted gene 11590 |
12098 |
0.2 |
chr12_39073634_39073815 | 12.77 |
Gm19563 |
predicted gene, 19563 |
75070 |
0.09 |
chr13_80827304_80827468 | 12.77 |
Arrdc3 |
arrestin domain containing 3 |
55998 |
0.12 |
chr5_85346759_85346954 | 12.76 |
Gm43567 |
predicted gene 43567 |
373918 |
0.01 |
chr4_97581822_97582075 | 12.75 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2648 |
0.32 |
chr4_81566140_81566319 | 12.74 |
Gm11765 |
predicted gene 11765 |
104497 |
0.07 |
chr4_13586923_13587108 | 12.74 |
Gm11825 |
predicted gene 11825 |
19019 |
0.22 |
chr1_82261369_82261537 | 12.69 |
Gm9747 |
predicted gene 9747 |
28341 |
0.15 |
chr1_152004745_152004896 | 12.68 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
50472 |
0.15 |
chr11_32086996_32087147 | 12.67 |
Gm12108 |
predicted gene 12108 |
14157 |
0.2 |
chr18_15391003_15391154 | 12.67 |
Aqp4 |
aquaporin 4 |
8924 |
0.2 |
chr14_123513860_123514089 | 12.63 |
Nalcn |
sodium leak channel, non-selective |
112902 |
0.06 |
chrX_10268865_10269016 | 12.59 |
Otc |
ornithine transcarbamylase |
16573 |
0.24 |
chr5_112239158_112239879 | 12.57 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr6_39242951_39243777 | 12.55 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr18_25678184_25678915 | 12.54 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chrX_7279894_7280070 | 12.54 |
Mir532 |
microRNA 532 |
31485 |
0.09 |
chr6_93849326_93849529 | 12.52 |
Gm22840 |
predicted gene, 22840 |
41188 |
0.16 |
chr2_4436351_4436936 | 12.52 |
Gm13175 |
predicted gene 13175 |
30027 |
0.16 |
chr2_14132895_14133287 | 12.49 |
Stam |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
1031 |
0.47 |
chr11_88481897_88482094 | 12.45 |
Gm11510 |
predicted gene 11510 |
48481 |
0.14 |
chr17_73713338_73713695 | 12.44 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
3063 |
0.29 |
chr5_133156480_133156656 | 12.40 |
Gm42625 |
predicted gene 42625 |
286774 |
0.01 |
chr2_41157435_41157586 | 12.38 |
Gm13460 |
predicted gene 13460 |
158653 |
0.04 |
chr1_33947103_33947453 | 12.37 |
Gm28631 |
predicted gene 28631 |
16407 |
0.12 |
chr5_97289441_97289719 | 12.36 |
Gm5560 |
predicted pseudogene 5560 |
24752 |
0.17 |
chr10_23127243_23127394 | 12.34 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
12122 |
0.24 |
chr10_110346437_110346592 | 12.33 |
Gm47338 |
predicted gene, 47338 |
32994 |
0.21 |
chr14_59887444_59887846 | 12.27 |
Gm9013 |
predicted gene 9013 |
152846 |
0.04 |
chr3_18054074_18054270 | 12.22 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
2 |
0.98 |
chr16_6042735_6042886 | 12.20 |
1700123O21Rik |
RIKEN cDNA 1700123O21 gene |
67225 |
0.14 |
chr4_70810746_70810927 | 12.19 |
Gm11227 |
predicted gene 11227 |
261837 |
0.02 |
chr2_79456556_79457006 | 12.19 |
Cerkl |
ceramide kinase-like |
4 |
0.51 |
chr15_95216740_95217275 | 12.19 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
54613 |
0.17 |
chr1_155233440_155234889 | 12.18 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr4_156341977_156342304 | 12.15 |
Vmn2r125 |
vomeronasal 2, receptor 125 |
2060 |
0.28 |
chr7_72592750_72592946 | 12.14 |
Gm37620 |
predicted gene, 37620 |
9141 |
0.21 |
chr9_13693996_13694212 | 12.13 |
Maml2 |
mastermind like transcriptional coactivator 2 |
31644 |
0.14 |
chr16_73108130_73108317 | 12.13 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
9235 |
0.31 |
chr2_139311595_139311791 | 12.12 |
Gm14071 |
predicted gene 14071 |
72647 |
0.12 |
chr18_49117752_49118229 | 12.11 |
Gm18993 |
predicted gene, 18993 |
54566 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 24.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.0 | 15.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
4.0 | 12.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.9 | 11.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
3.9 | 15.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
3.7 | 22.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
3.7 | 18.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.7 | 11.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.4 | 10.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
3.3 | 9.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
3.3 | 13.1 | GO:0007412 | axon target recognition(GO:0007412) |
3.2 | 12.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.1 | 12.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.1 | 3.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.9 | 14.7 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.9 | 8.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
2.8 | 2.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
2.8 | 8.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.8 | 13.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.7 | 8.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.6 | 7.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.5 | 7.4 | GO:0030421 | defecation(GO:0030421) |
2.5 | 7.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.5 | 7.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.4 | 4.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.4 | 19.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.4 | 7.2 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
2.4 | 7.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.2 | 4.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 13.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.2 | 8.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.1 | 8.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.1 | 6.3 | GO:0021586 | pons maturation(GO:0021586) |
2.0 | 14.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.0 | 4.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.0 | 6.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.0 | 6.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.0 | 3.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.9 | 5.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.9 | 9.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.9 | 5.7 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 5.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.9 | 3.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.9 | 9.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.8 | 5.5 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.8 | 5.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.8 | 5.4 | GO:0001927 | exocyst assembly(GO:0001927) |
1.7 | 8.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.7 | 1.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 10.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.6 | 22.7 | GO:0008038 | neuron recognition(GO:0008038) |
1.6 | 1.6 | GO:1902837 | amino acid import into cell(GO:1902837) |
1.6 | 1.6 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
1.6 | 7.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.6 | 1.6 | GO:2000981 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
1.6 | 6.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.5 | 7.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.5 | 4.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.5 | 18.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.5 | 4.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.4 | 11.4 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 1.4 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
1.4 | 5.6 | GO:0021764 | amygdala development(GO:0021764) |
1.4 | 1.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.3 | 12.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.3 | 1.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.3 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.3 | 3.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 2.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.3 | 5.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.3 | 5.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.3 | 2.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.2 | 5.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.2 | 2.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 3.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.2 | 4.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.2 | 7.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.2 | 1.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
1.2 | 4.7 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 3.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.2 | 9.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 8.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.2 | 4.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.1 | 5.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.1 | 5.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 5.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.1 | 4.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.1 | 5.5 | GO:0080009 | mRNA methylation(GO:0080009) |
1.1 | 3.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.1 | 3.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 4.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 3.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 3.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.0 | 6.2 | GO:1901660 | calcium ion export(GO:1901660) |
1.0 | 2.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.0 | 3.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.0 | 3.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 2.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.0 | 5.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.0 | 3.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.0 | 5.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.0 | 2.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.0 | 3.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 4.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.0 | 4.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.0 | 2.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.0 | 4.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.0 | 3.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.0 | 2.9 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 3.8 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.0 | 3.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.9 | 3.8 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 2.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 5.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 2.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.9 | 0.9 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 1.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 2.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 4.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 2.7 | GO:0090135 | actin filament branching(GO:0090135) |
0.9 | 4.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.9 | 2.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 3.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.9 | 6.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.9 | 2.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.9 | 4.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.8 | 1.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.8 | 2.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 2.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 2.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.8 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.8 | 8.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.8 | 3.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 3.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.8 | 0.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.8 | 3.1 | GO:0019230 | proprioception(GO:0019230) |
0.8 | 6.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.8 | 3.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.7 | 6.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.7 | 8.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 5.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 1.5 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.7 | 5.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 1.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.7 | 2.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.7 | 2.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 1.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 1.4 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 1.4 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.7 | 2.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 0.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 1.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 0.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.7 | 3.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 0.7 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.7 | 4.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 2.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 3.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.7 | 1.4 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.7 | 2.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.7 | 1.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.7 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 0.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 53.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.7 | 7.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 11.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 3.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 1.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.6 | 1.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.6 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.6 | 1.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 1.9 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.6 | 1.9 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.6 | 4.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 2.5 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.6 | 3.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.6 | 1.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 1.9 | GO:0008050 | female courtship behavior(GO:0008050) |
0.6 | 1.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 1.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.6 | 14.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.6 | 3.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.6 | 5.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 2.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 4.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 3.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.6 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 8.8 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.6 | 6.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 1.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 1.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.6 | 3.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 2.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 5.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.6 | 2.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.6 | 1.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.6 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 2.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 1.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 0.6 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.6 | 8.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 1.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.5 | 1.1 | GO:0070268 | cornification(GO:0070268) |
0.5 | 3.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 5.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 4.9 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.5 | 1.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 1.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 5.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.5 | 3.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 2.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 0.5 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 2.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 2.5 | GO:0032196 | transposition(GO:0032196) |
0.5 | 16.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 1.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 0.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.5 | 2.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 3.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.5 | 1.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 0.5 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.5 | 2.4 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.5 | 1.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 2.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 0.5 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.5 | 1.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 1.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 1.4 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 2.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 3.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 4.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 0.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.4 | 1.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 2.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 0.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 | 2.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 0.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 0.9 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 7.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.4 | 0.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 2.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.4 | 0.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 3.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 1.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 2.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 3.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.4 | 3.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.4 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 1.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 2.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:0035482 | gastric motility(GO:0035482) |
0.4 | 1.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 2.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.4 | 4.8 | GO:0060004 | reflex(GO:0060004) |
0.4 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 2.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 2.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 3.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.4 | 0.8 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.4 | 3.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 0.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.4 | 1.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 0.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.4 | 2.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.4 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 1.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 2.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 5.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 1.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 0.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.4 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 1.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 6.5 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 1.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 1.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 0.7 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.4 | 2.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.4 | 1.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 3.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 0.4 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 1.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 1.4 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 0.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.3 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 2.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 1.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 1.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 1.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 2.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 1.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 2.2 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.9 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.9 | GO:0006203 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.3 | 2.2 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 3.4 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.3 | 1.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.3 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 1.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 0.3 | GO:0072179 | nephric duct formation(GO:0072179) |
0.3 | 2.9 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 2.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 2.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 5.5 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.3 | 0.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 1.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 0.6 | GO:0099612 | protein localization to axon(GO:0099612) |
0.3 | 0.3 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 3.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 0.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 1.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.3 | 1.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.3 | 1.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 1.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 0.8 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 0.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 2.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.8 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 1.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 2.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.8 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.3 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.8 | GO:0015824 | proline transport(GO:0015824) |
0.3 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.8 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 1.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 3.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 0.3 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.3 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 2.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.7 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 0.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 1.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 2.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 2.9 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.2 | 1.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 1.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.5 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 4.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.8 | GO:0060384 | innervation(GO:0060384) |
0.2 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 6.1 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 1.3 | GO:0002209 | behavioral defense response(GO:0002209) |
0.2 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 1.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 2.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 2.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 2.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 18.0 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 3.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 1.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 1.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.4 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 1.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 5.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 2.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 3.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 7.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.6 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 3.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.2 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.2 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.2 | 3.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 1.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 1.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.5 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 1.5 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.5 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.2 | 2.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 3.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 5.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 1.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 5.5 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.3 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 1.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 1.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 1.6 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.1 | 2.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.8 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.8 | GO:0001964 | startle response(GO:0001964) |
0.1 | 1.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.3 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 1.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.1 | 1.7 | GO:0015844 | monoamine transport(GO:0015844) |
0.1 | 1.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.1 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.1 | 0.5 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.3 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.1 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.6 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 2.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 1.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 1.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.2 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.5 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 2.1 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.0 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
0.0 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 34.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
3.6 | 10.9 | GO:0072534 | perineuronal net(GO:0072534) |
2.9 | 8.8 | GO:0097441 | basilar dendrite(GO:0097441) |
2.6 | 31.5 | GO:0043194 | axon initial segment(GO:0043194) |
2.6 | 7.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.5 | 7.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.4 | 18.9 | GO:0043083 | synaptic cleft(GO:0043083) |
2.3 | 7.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.3 | 23.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.7 | 5.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.6 | 4.8 | GO:0033010 | paranodal junction(GO:0033010) |
1.5 | 2.9 | GO:0042585 | germinal vesicle(GO:0042585) |
1.4 | 4.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.4 | 12.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.2 | 7.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.2 | 4.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.2 | 8.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.1 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 17.2 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 3.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 5.1 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 10.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.9 | 12.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 3.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 2.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 3.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.8 | 3.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.8 | 14.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 20.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 10.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.8 | 8.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.7 | 2.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.7 | 8.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 5.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 2.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 2.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 6.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 1.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 3.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 2.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 2.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 1.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.6 | 21.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 15.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 3.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 2.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 2.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.6 | 2.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 4.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 3.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 4.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 4.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 3.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 18.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 1.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 24.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 3.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 1.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 59.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 2.5 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 5.8 | GO:0001741 | XY body(GO:0001741) |
0.4 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 1.6 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 4.2 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 5.7 | GO:0043205 | fibril(GO:0043205) |
0.4 | 4.7 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 33.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 0.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 1.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 2.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 18.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 2.4 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 2.6 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 4.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 1.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 19.1 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 2.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 2.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.8 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.8 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 6.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 8.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 4.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 2.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 2.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 18.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 1.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 1.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.0 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 2.1 | GO:0045202 | synapse(GO:0045202) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
5.9 | 17.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.9 | 7.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.9 | 15.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.3 | 9.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.0 | 14.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.9 | 11.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
2.9 | 8.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.8 | 8.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.6 | 18.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.4 | 9.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.1 | 17.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.1 | 6.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.9 | 15.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.9 | 9.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.9 | 7.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.7 | 8.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.6 | 8.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.5 | 3.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 9.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 7.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.5 | 4.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.5 | 7.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 2.8 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.4 | 12.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 3.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.3 | 7.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.3 | 7.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.3 | 1.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.3 | 13.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.2 | 4.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.2 | 10.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.2 | 10.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.2 | 3.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.1 | 3.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 10.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 3.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 5.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.1 | 5.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.0 | 6.3 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.0 | 6.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 6.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 2.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 11.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.9 | 3.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 15.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 11.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.9 | 4.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 2.7 | GO:0005119 | smoothened binding(GO:0005119) |
0.9 | 4.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.9 | 2.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.9 | 4.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.9 | 18.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.9 | 2.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 4.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 3.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 0.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 4.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 15.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 3.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.8 | 10.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.8 | 15.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.8 | 2.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 3.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 2.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 2.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.7 | 2.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 2.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 1.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.7 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 2.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 3.4 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.6 | 7.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 3.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 4.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 1.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 2.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.6 | 6.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.6 | 1.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 3.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 3.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 4.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.6 | 6.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 6.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 1.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 1.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 5.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.6 | 5.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 0.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.6 | 8.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 2.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 2.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 2.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 17.1 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 1.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.5 | 1.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 1.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 5.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 7.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 11.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 1.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 3.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 3.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 5.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 4.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 2.5 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 1.2 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.4 | 6.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 2.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 2.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 5.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 2.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 1.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 4.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 1.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 3.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 2.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 3.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 11.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 4.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 2.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 7.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 2.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 2.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 2.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 7.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 0.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 5.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 4.5 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.3 | 2.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 2.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 2.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 10.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 3.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 2.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 3.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 2.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 3.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 1.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.7 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 4.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 3.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 3.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 3.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 2.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.4 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 3.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 2.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.7 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 4.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.4 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 14.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 13.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 2.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 5.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 16.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 8.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 6.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 9.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 3.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 4.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 0.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 11.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 10.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 10.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 10.4 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 4.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 4.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 3.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 13.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 25.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 4.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 4.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 4.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 44.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.7 | 24.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.4 | 21.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.3 | 19.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 10.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 26.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.2 | 13.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 6.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 20.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 10.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.9 | 22.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.9 | 38.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 9.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 11.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.7 | 8.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 5.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 13.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 4.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 8.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 1.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 7.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 9.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 4.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 4.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 1.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.5 | 2.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 4.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 5.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 6.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 5.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 4.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 5.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 7.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.4 | 7.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 4.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 2.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 5.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 6.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 5.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 2.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 2.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 2.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 4.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 5.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 3.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 3.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 3.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 2.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 1.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 3.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 0.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 3.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 11.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 5.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |